In January 2019, Charles River Laboratories and Atomwise formed an alliance to provide integrated, AI-Driven drug discovery.
History and Approach
Atomwise’s technology was first developed by Dr. Wallach, a PhD student at the University of Toronto. The technology uses convolutional neural networks to predict the bioactivity of small molecules for drug discovery applications. It uses a statistical approach that extracts insights from experimental affinity measurements and protein structures to predict the binding of small molecules to proteins.
This tool allows chemists to pursue hit discovery, lead optimization and toxicity predictions. Atomwise analyzes billions of compounds to identify a small, specific subset for synthesis and testing.
AtomNet is Atomwise's deep convolutional network.
AtomNet represents a protein-ligand pair as a set of 3-dimensional volumetric pixels containing channels for carbon, oxygen, nitrogen, etc atom types. AtomNet applies local convolutional filters to structural target information to predict new active molecules for targets with no previously known modulators.
Atomwise Announces Largest China-US Collaboration for AI Drug Discovery
Atomwise announced a collaboration with Hansoh Pharmaceutical Group Company Limited, a biopharmaceutical company in China, to design and discover potential drug candidates for up to eleven undisclosed target proteins in multiple therapeutic areas.
Atomwise signs four new deals for AI-based drug discovery
Atomwise and DNDi collaborate to advance drug development using AI for neglected diseases.
Atomwise raises a $45,000,000 series A round from Khosla Ventures, B Capital Group, Threshold Ventures, Y Combinator, DCVC Bio, DFJ, Monsanto Growth Ventures, Tencent, Dolby Family Ventures and Baidu Ventures.
Atomwise raises a $6,000,000 seed round from Khosla Ventures, AME Cloud Ventures, OS Fund, Threshold Ventures, Draper Associates, Data Collective, Mission and Market and Farzad Nazem.
Atomwise raises a $120,000 seed round from Y Combinator and David E. Weekly.
David E. Weekly
Documentaries, videos and podcasts
- Artificial intelligence (AI)Artificial intelligence (AI) is intelligence exhibited by machines.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Cluster: Artificial intelligenceA cluster of topics related to artificial intelligence.
- Y CombinatorY Combinator (also known as YC) is a US based seed accelerator, which was started in March 2005.
- Convolutional neural networkA type of neural network which uses overlapping input neurons modeled on the behavior of human visual cortex. Convolutional neural networks are best known for their use in image analysis, specifically object recognition.